Search Within

Jianda Yuan

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Meeting Abstract (13)
  2. Journal Article (12)
Groups
  1. Department of Pathology and Laboratory Medicine (25)
  2. Department of Medicine (24)
  3. Solid Tumor Oncology Division (24)
  4. GSK Faculty (23)
  5. Melanoma and Immunotherapeutics Service (23)
  6. Surgery (17)

More Groups

People
  1. Jedd Wolchok (23)
  2. Clifford Hudis (12)
  3. Edi Brogi (12)
  4. Heather Mcarthur (12)
  5. James Allison (12)
  6. Larry Norton (12)

More People

Years
  1. 2018 (1)
  2. 2016 (2)
  3. 2015 (3)
  4. 2014 (4)
  5. 2013 (6)
  6. 2012 (2)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. Cancer Research (3)
  3. Cancer Immunology Research (2)
  4. Cancer Immunology, Immunotherapy (2)
  5. Journal for ImmunoTherapy of Cancer (2)
  6. Proceedings of the National Academy of Sciences of the United States of America (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (7)
  2. American Association for Cancer Research (6)
  3. Springer (3)
  4. Biomed Central Ltd (2)
  5. National Academy of Sciences (2)
  6. Academy of Cancer Immunology (1)

More Publishers

Results (25)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Robust antitumor responses result from local chemotherapy and CTLA-4 blockade
    Journal Article

    Ariyan, C. E.; Brady, M. S.; Siegelbaum, R. H.; Hu, J.; Bello, D. M.; Rand, J.; Fisher, C.; Lefkowitz, R. A.; Panageas, K. S.; Pulitzer, M.; more...
    Cancer Immunology Research (2018)

    Fulltext@MSK | Save
  • A pilot study of preoperative single-dose ipilimumab and/or cryoablation in women with early-stage breast cancer with comprehensive immune profiling
    Journal Article

    McArthur, H. L.; Diab, A.; Page, D. B.; Yuan, J.; Solomon, S. B.; Sacchini, V.; Comstock, C.; Durack, J. C.; Maybody, M.; Sung, J.; more...
    Clinical Cancer Research (2016)

    Fulltext@MSK | Save
  • Deep sequencing of T-cell receptor DNA as a biomarker of clonally expanded TILs in breast cancer after immunotherapy
    Journal Article

    Page, D. B.; Yuan, J.; Redmond, D.; Wen, Y. H.; Durack, J. C.; Emerson, R.; Solomon, S.; Dong, Z.; Wong, P.; Comstock, C.; more...
    Cancer Immunology Research (2016)

    Fulltext@MSK | Save
  • Characterization of dominant T-cell clones by T-cell receptor (TCR) deep sequencing as a potential predictive biomarker to neoadjuvant trastuzumab (tras) in HER2-positive (HER2+) breast cancer
    Meeting Abstract

    Page, D. B.; Wen, Y. H.; Brogi, E.; Yuan, J. D.; Emerson, R. O.; Patil, S.; Dang, C. T.; Norton, L.; Hudis, C. A.; Mcarthur, H. L.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Integrated immunologic assessment of tumor infiltrating lymphocytes (TILs) and peripheral blood to assess synergy of cryoablation (cryo) plus ipilimumab (ipi) in early stage breast cancer (ESBC) patients (pts)
    Meeting Abstract

    Page, D.; Yuan, J. D.; Diab, A.; Dong, Z.; Ginsberg, A.; Wong, P.; Emerson, R.; Redmond, D.; Blum, B.; Mu, Z.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
    Journal Article

    Rizvi, N. A.; Hellmann, M. D.; Snyder, A.; Kvistborg, P.; Makarov, V.; Havel, J. J.; Lee, W.; Yuan, J.; Wong, P.; Ho, T. S. ; more...
    Science (2015)

    Fulltext@MSK | Save
  • Matched T cell repertoire analysis of peripheral blood and tumor-infiltrating lymphocytes (TILs) in early stage breast cancer (ESBC) patients (pts) treated with pre-operative cryoablation (cryo) and/or Ipilimumab (Ipi)
    Meeting Abstract

    Page, D. B.; McArthur, H.; Dong, Z.; Wong, P.; Emerson, R.; Mu, Z.; Zhao, C.; Comstock, C.; Morris, E.; Comen, E.; more...
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save
  • T-cell receptor (TCR) DNA deep sequencing to evaluate clonality of tumor-infiltrating lymphocytes (TILs) in early stage breast cancer patients (pts) receiving preoperative cryoablation (cryo) and/or ipilinournab (ipi)
    Meeting Abstract

    Page, D. B.; Diab, A.; Yuan, J. D.; Dong, Z. W.; Emerson, R.; Robins, H.; Redmond, D.; Zhao, C. J.; Mu, Z. Y.; Wong, P.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A pilot study of preoperative (Pre-op), single-dose ipilimumab (Ipi) and/or cryoablation (Cryo) in women (pts) with early-stage/resectable breast cancer (ESBC)
    Meeting Abstract

    Diab, A.; Mcarthur, H. L.; Solomon, S. B.; Sacchini, V.; Comstock, C.; Maybody, M.; Durack, J. C.; Blum, B.; Yuan, J. D.; Patil, S.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Tumor and systemic immune responses to preoperative (pre-op) cryoablation (cryo) plus immune therapy with ipilimumab (ipi) in early-stage breast cancer (ESBC)
    Meeting Abstract

    Page, D. B.; Yuan, J. D.; Ginsberg, A.; Dong, Z.; Wong, P.; Emerson, R.; Sung, J. S.; Comstock, C.; Solomon, S. B.; Sacchini, V.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save